The protective role of Nrf2 against aristolochic acid-induced renal tubular epithelial cell injury

References

• Aleksunes LM, Goedken MJ, Rockwell CE, Thomale J, Manautou JE, Klaassen CD. 2010. Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity. J Pharmacol Exp Ther. 335(1):2–12.
   PubMed Web of Science ®Google Scholar
• Aminzadeh MA, Reisman SA, Vaziri ND, Khazaeli M, Yuan J, Meyer CJ. 2014. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease. Xenobiotica. 44(6):570–578.
   PubMed Web of Science ®Google Scholar
• Bunel V, Antoine MH, Stevigny C, Nortier J, Duez P. 2016. New in vitro insights on a cell death pathway induced by magnolol and honokiol in aristolochic acid tubulotoxicity. Food Chem Toxicol. 87:77–87.
   PubMed Web of Science ®Google Scholar
• Chen Q, Peng H, Dong L, Chen L, Ma X, Peng Y, Dai S, Liu Q. 2016. Activation of the NRF2-ARE signalling pathway by the Lentinula edodes polysaccharose LNT alleviates ROS-mediated cisplatin nephrotoxicity. Int Immunopharmacol. 36:1–8.
   PubMed Web of Science ®Google Scholar
• Decleves AE, Jadot I, Colombaro V, Martin B, Voisin V, Nortier J, Caron N. 2016. Protective effect of nitric oxide in aristolochic acid-induced toxic acute kidney injury: an old friend with new assets. Exp Physiol. 101(1):193–206.
   PubMed Web of Science ®Google Scholar
• Depierreux M, Van Damme B, Vanden HK, Vanherweghem JL. 1994. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis. 24(2):172–180.
   PubMed Web of Science ®Google Scholar
• Huang Y, Li W, Su ZY, Kong AN. 2015. The complexity of the Nrf2 pathway: beyond the antioxidant response. J Nutr Biochem. 26(12):1401–1413.
   PubMed Web of Science ®Google Scholar
• Jadot I, Decleves AE, Nortier J, Caron N. 2017. An integrated view of aristolochic acid nephropathy: update of the literature. Int J Mol Sci. 18(2):297.
   Web of Science ®Google Scholar
• Jelaković B, Karanović S, Vuković-Lela I, Miller F, Edwards KL, Nikolić J, Tomić K, Slade N, Brdar B, Turesky RJ, et al. 2012. Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid. Kidney Int. 81(6):559–567.
   PubMed Web of Science ®Google Scholar
• Jiang T, Tian F, Zheng H, Whitman SA, Lin Y, Zhang Z, Zhang N, Zhang DD. 2014. Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-κB-mediated inflammatory response. Kidney Int. 85(2):333–343.
   PubMed Web of Science ®Google Scholar
• Kim BH, Lee ES, Choi R, Nawaboot J, Lee MY, Lee EY, Kim HS, Chung CH. 2016. Protective effects of curcumin on renal oxidative stress and lipid metabolism in a rat model of type 2 diabetic nephropathy. Yonsei Med J. 57(3):664–673.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Vaziri ND. 2010. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Renal Physiol. 298(3):F662–F671.
   PubMed Web of Science ®Google Scholar
• Kotlo KU, Yehiely F, Efimova E, Harasty H, Hesabi B, Shchors K, Einat P, Rozen A, Berent E, Deiss LP. 2003. Nrf2 is an inhibitor of the Fas pathway as identified by Achilles’ Heel Method, a new function-based approach to gene identification in human cells. Oncogene. 22(6):797–806.
   PubMed Web of Science ®Google Scholar
• Li CZ, Jin HH, Sun HX, Zhang ZZ, Zheng JX, Li SH, Han SH. 2016. Eriodictyol attenuates cisplatin-induced kidney injury by inhibiting oxidative stress and inflammation. Eur J Pharmacol. 772:124–130.
   PubMed Web of Science ®Google Scholar
• Li YC, Tsai SH, Chen SM, Chang YM, Huang TC, Huang YP, Chang CT, Lee JA. 2012. Aristolochic acid-induced accumulation of methylglyoxal and Nepsilon-(carboxymethyl)lysine: an important and novel pathway in the pathogenic mechanism for aristolochic acid nephropathy. Biochem Biophys Res Commun. 423(4):832–837.
   PubMed Web of Science ®Google Scholar
• Liu M, Grigoryev DN, Crow MT, Haas M, Yamamoto M, Reddy SP, Rabb H. 2009. Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice. Kidney Int. 76(3):277–285.
   PubMed Web of Science ®Google Scholar
• Liu M, Reddy NM, Higbee EM, Potteti HR, Noel S, Racusen L, Kensler TW, Sporn MB, Reddy SP, Rabb H. 2014. The Nrf2 triterpenoid activator, CDDO-imidazolide, protects kidneys from ischemia-reperfusion injury in mice. Kidney Int. 85(1):134–141.
   PubMed Web of Science ®Google Scholar
• Lu M, Wang P, Qiao Y, Jiang C, Ge Y, Flickinger B, Malhotra DK, Dworkin LD, Liu Z, Gong R. 2019. GSK3β-mediated Keap1-independent regulation of Nrf2 antioxidant response: a molecular rheostat of acute kidney injury to chronic kidney disease transition. Redox Biol. 26:101275.
   PubMed Web of Science ®Google Scholar
• Ma Q, He X. 2012. Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. Pharmacol Rev. 64(4):1055–1081.
   PubMed Web of Science ®Google Scholar
• Niture SK, Jaiswal AK. 2012. Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis. J Biol Chem. 287(13):9873–9886.
   PubMed Web of Science ®Google Scholar
• Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, et al. 2000. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med. 342(23):1686–1692.
   PubMed Web of Science ®Google Scholar
• O’Connell MA, Hayes JD. 2015. The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic. Biochem Soc Trans. 43(4):687–689.
   PubMedGoogle Scholar
• Pozdzik AA, Salmon IJ, Debelle FD, Decaestecker C, Van den Branden C, Verbeelen D, Deschodt-Lanckman MM, Vanherweghem JL, Nortier JL. 2008. Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int. 73(5):595–607.
   PubMed Web of Science ®Google Scholar
• Reginster F, Jadoul M, van Ypersele D. 1997. Chinese herbs nephropathy presentation, natural history and fate after transplantation. Nephrol Dial Transplant. 12(1):81–86.
   PubMed Web of Science ®Google Scholar
• Romanov V, Whyard T, Bonala R, Johnson F, Grollman A. 2011. Glutamate dehydrogenase requirement for apoptosis induced by aristolochic acid in renal tubular epithelial cells. Apoptosis. 16(12):1217–1228.
   PubMed Web of Science ®Google Scholar
• Romanov V, Whyard TC, Waltzer WC, Grollman AP, Rosenquist T. 2015. Aristolochic acid-induced apoptosis and G2 cell cycle arrest depends on ROS generation and MAP kinases activation. Arch Toxicol. 89(1):47–56.
   PubMed Web of Science ®Google Scholar
• Shokeir AA, Barakat N, Hussein AM, Awadalla A, Harraz AM, Khater S, Hemmaid K, Kamal AI. 2015. Activation of Nrf2 by ischemic preconditioning and sulforaphane in renal ischemia/reperfusion injury: a comparative experimental study. Physiol Res. 64(3):313–323.
   PubMed Web of Science ®Google Scholar
• Tapia E, Zatarain-Barron ZL, Hernandez-Pando R, Zarco-Marquez G, Molina-Jijon E, Cristobal-Garcia M, Santamaria J, Pedraza-Chaverri J. 2013. Curcumin reverses glomerular hemodynamic alterations and oxidant stress in 5/6 nephrectomized rats. Phytomedicine. 20(3–4):359–366.
   PubMed Web of Science ®Google Scholar
• Tebay LE, Robertson H, Durant ST, Vitale SR, Penning TM, Dinkova-Kostova AT, Hayes JD. 2015. Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Free Radic Biol Med. 88(B):108–146.
   PubMedGoogle Scholar
• Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P. 2008. Redox regulation of cell survival. Antioxid Redox Signal. 10(8):1343–1374.
   PubMed Web of Science ®Google Scholar
• Vanherweghem JL, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, Jadoul M, Richard C, Vandervelde D, Verbeelen D, Vanhaelen-Fastre R, et al. 1993. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet. 341(8842):387–391.
   PubMed Web of Science ®Google Scholar
• Wu J, Liu X, Fan J, Chen W, Wang J, Zeng Y, Feng X, Yu X, Yang X. 2014. Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway. Toxicology. 318:22–31.
   PubMed Web of Science ®Google Scholar
• Yu FY, Wu TS, Chen TW, Liu BH. 2011. Aristolochic acid I induced oxidative DNA damage associated with glutathione depletion and ERK1/2 activation in human cells. Toxicol in Vitro. 25(4):810–816.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Li S, Wu J, Chen W, Sun H, Peng W, Yu X, Yang X. 2014. Autophagy inhibitors promoted aristolochic acid I induced renal tubular epithelial cell apoptosis via mitochondrial pathway but alleviated nonapoptotic cell death in mouse acute aritolochic acid nephropathy model. Apoptosis. 19(8):1215–1224.
   PubMed Web of Science ®Google Scholar
• Zhao YY, Wang HL, Cheng XL, Wei F, Bai X, Lin RC, Vaziri ND. 2015. Metabolomics analysis reveals the association between lipid abnormalities and oxidative stress, inflammation, fibrosis, and Nrf2 dysfunction in aristolochic acid-induced nephropathy. Sci Rep. 5:12936.
   PubMed Web of Science ®Google Scholar
• Zhou L, Fu P, Huang XR, Liu F, Lai KN, Lan HY. 2010. Activation of p53 promotes renal injury in acute aristolochic acid nephropathy. J Am Soc Nephrol. 21(1):31–41.
   PubMed Web of Science ®Google Scholar